ZARGAR, Abdul Hamid et al.
 Patient-centered Assessment of the Efficacy and Safety of Vildagliptin Sustained-release Tablet (100 mg) Relative to Sitagliptin (100 mg) in Patients with Type 2 Diabetes Mellitus Inadequately Controlled on MEtformin (PRIME-Vilda Trial).
<strong>Medical Research Archives</strong>, [S.l.], v. 13, n. 5, may 2025.
ISSN 2375-1924.
Available at: &lt;<a href="https://esmed.org/MRA/mra/article/view/6599" target="_new">https://esmed.org/MRA/mra/article/view/6599</a>&gt;. Date accessed: 15 july 2025.
doi: <a href="https://doi.org/10.18103/mra.v13i5.6599">https://doi.org/10.18103/mra.v13i5.6599</a>.